Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Recent patents divulge new anticancer agents

March 4, 2008

Ferring submits NDA for prostate cancer drug candidate degarelix

March 3, 2008

Calorie restriction protects against carcinogenesis via Nrf2 signaling

March 3, 2008

Serenex and the NCI enter clinical trial agreement for Hsp90 inhibitor SNX-5422

March 3, 2008

Everolimus improves progression-free survival in advanced kidney cancer

March 3, 2008

Anadys initiates phase I ANA-773 trial in cancer patients

Feb. 29, 2008

AstraZeneca presents update on clinical development of Recentin in NSCLC and colorectal cancer

Feb. 29, 2008

VioQuest and the National Cancer Institute enter agreement for Akt inhibitor VQD-002

Feb. 28, 2008

ADVR signs research agreement with Northeastern University for AVR-118 in cancer

Feb. 28, 2008

Bionomics initiates treatment in phase I clinical trial of BNC-105 anticancer drug

Feb. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...